O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+55.65%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.98B
AUM Growth
+$6.98B
(+34%)
Cap. Flow
+$27.1M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
37.73%
Holding
152
New
37
Increased
17
Reduced
34
Closed
13
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$109M |
| 2 |
89bio
ETNB
|
$105M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$104M |
| 4 |
Danaher
DHR
|
$98.1M |
| 5 |
Glaukos
GKOS
|
$84.3M |
Top Sells
| 1 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$96.3M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
$79.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$68.7M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$58.9M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$56.6M |
Sector Composition
| 1 | Healthcare | 98.02% |
| 2 | Financials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Personalis
PSNL
$430M
| $5.27M | 0.08% |
483,842
| – | – |
|
102
Synlogic
SYBX
$17.4M
| $5.24M | 0.07% |
2,029,996
| – | – |
|
103
Incyte
INCY
$17B
| $5.2M | 0.07% |
+59,500
| New | +$5.2M |
|
|
ARNA
104
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5M | 0.07% |
110,000
| – | – |
|
105
Acadia Pharmaceuticals
ACAD
$4.34B
| $4.11M | 0.06% |
96,143
| – | – |
|
106
Intellia Therapeutics
NTLA
$1.26B
| $3.85M | 0.05% |
262,100
-65,500
| -20% | -$961K |
|
107
AstraZeneca
AZN
$255B
| $3.47M | 0.05% |
+69,600
| New | +$3.47M |
|
108
Sanofi
SNY
$122B
| $3.43M | 0.05% |
+68,400
| New | +$3.43M |
|
|
WHWK
109
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $3.24M | 0.05% |
5,193,946
| – | – |
|
110
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.93M | 0.04% |
+34,700
| New | +$2.93M |
|
111
KalVista Pharmaceuticals
KALV
$713M
| $2.86M | 0.04% |
160,541
+121,808
| +314% | +$2.17M |
|
|
ICPT
112
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.83M | 0.04% |
22,800
-9,400
| -29% | -$1.16M |
|
|
FLXN
113
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.75M | 0.04% |
+133,000
| New | +$2.75M |
|
114
Curis
CRIS
$21.5M
| $2.31M | 0.03% |
1,358,363
+116,869
| +9% | +$199K |
|
|
MYOK
115
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.03M | 0.03% |
27,900
-755,132
| -96% | -$55M |
|
116
Syndax Pharmaceuticals
SNDX
$1.39B
| $1.86M | 0.03% |
212,000
| – | – |
|
117
Eledon Pharmaceuticals
ELDN
$155M
| $1.85M | 0.03% |
3,183,314
| – | – |
|
118
Mirum Pharmaceuticals
MIRM
$3.75B
| $1.75M | 0.03% |
+71,300
| New | +$1.75M |
|
|
ADAP
119
Adaptimmune Therapeutics
ADAP
$13.9M
| $1.62M | 0.02% |
1,350,655
| – | – |
|
|
IMGN
120
DELISTED
Immunogen Inc
IMGN
| $1.46M | 0.02% |
+286,800
| New | +$1.46M |
|
121
Insmed
INSM
$30.3B
| $1.41M | 0.02% |
59,000
-503,300
| -90% | -$12M |
|
122
Protagonist Therapeutics
PTGX
$3.62B
| $1.35M | 0.02% |
+191,209
| New | +$1.35M |
|
|
OTIC
123
DELISTED
Otonomy, Inc.
OTIC
| $1.34M | 0.02% |
+350,700
| New | +$1.34M |
|
124
Spero Therapeutics
SPRO
$117M
| $1.27M | 0.02% |
131,653
-9,056
| -6% | -$87.1K |
|
125
Sutro Biopharma
STRO
$85.6M
| $1.15M | 0.02% |
+104,800
| New | +$1.15M |
|